Drawing for FLASHBEADS

USPTO serial 78715149

FLASHBEADS

Reviewed by CopyMark Law Group

Reg. 3613896Status 710
Filing date
Status date
Registration date
Apr 28, 2009
Examiner
MIZELLE HOWARD, DEZMONA JULYE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with FLASHBEADS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David W. Osborne

DAVID W. OSBORNE THORPE NORTH & WESTERN, LLPPO BOX 1219SANDY, UT 84091-1219UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Fast disintegrating beads that are a form of the actual pharmaceuticals and nutritional supplements for oral delivery of dietary fiber, stannol esters, and therapeutically active substances, namely, antitussives, antihistamines, decongestants, alkaloids, minerals, herbs, laxatives, vitamins, antacids, ion exchange resins, anti-cholesterolemics, antiarrhythmics, antipyretics, analgesics, aspirin, non-steroidal anti-inflammatory drugs ("NSAID") and opioids, appetite suppressants, expectorants, anti-anxiety agents, anti-ulcer agents, anti-inflammatory substances, coronary dilators, cerebral dilators, peripheral vasodilators, anti-infectives, psycho-tropics, antimanics, stimulants, gastrointestinal agents, sedatives, anti-diarrheal preparations, anti-anginal drugs, vasodilators, anti-hypertensive drugs, vasoconstrictors, migraine treatments, antibiotics, tranquilizers, psycho-therapeutics, anti-psychotics, antitumor drugs, anticoagulants, antithrombotic drugs, hypnotics, anti-emetics, anti-nausants, anti-convulsants, neuromuscular drugs, hyper-and hypoglycemic spasmodics, uterine relaxants, mineral and nutritional additives, antiobesity drugs, anabolic drugs, erythropoetic drugs, antiasthmatics, cough suppressants, cough and cold medications, anti-smoking medications, cardiovascular medications, mucolytics, anti-uricemic drugs and mixtures thereof, for pharmaceutical, veterinary, medical and dietary useSECTION 8 - CANCELLEDJan 19, 2009

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 4, 2015C8..CANCELLED SEC. 8 (6-YR)—
Apr 28, 2009R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 24, 2009REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Mar 23, 2009CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 11, 2009SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 10, 2009AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 26, 2009EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jan 24, 2009IUAFUSE AMENDMENT FILED—
Jul 23, 2008EX2GSOU EXTENSION 2 GRANTED—
Jul 23, 2008EXT2SOU EXTENSION 2 FILED—
Jul 23, 2008EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 24, 2008EX1GSOU EXTENSION 1 GRANTED—
Jan 24, 2008EXT1SOU EXTENSION 1 FILED—
Jan 24, 2008EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 24, 2007NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 1, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 11, 2007NPUBNOTICE OF PUBLICATION—
Mar 6, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 6, 2007ALIEASSIGNED TO LIE—
Feb 3, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 17, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 17, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 17, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 3, 2006CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 2, 2006CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 10, 2006TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 5, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 5, 2006ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 5, 2006REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 5, 2006TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 5, 2006CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 5, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 26, 2006DOCKASSIGNED TO EXAMINER—
Sep 23, 2005NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance